EnliticASX:ENL -16.67% EBITDA Margin % is -309.83% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Enlitic ranks worse than 95.51% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Enlitic's EBITDA for the
six
months ended in Dec. 2025 was A$-8.89 Mil. Enlitic's Revenue for the
six
months ended in Dec. 2025 was A$2.87 Mil. Therefore, Enlitic's EBITDA margin for the quarter that ended in Dec. 2025 was -309.83%.
Enlitic (ASX:ENL) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Enlitic EBITDA Margin % Related Terms
Enlitic EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Enlitic's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enlitic EBITDA Margin % Chart
Enlitic Annual Data
Trend
Dec23
Dec24
Dec25
EBITDA Margin %
-3,044.80
-1,398.42
-332.85
Enlitic Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
EBITDA Margin %
0.00
-3,368.73
-939.51
-356.06
-309.83
ASX:ENL vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Enlitic's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enlitic EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Enlitic's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Enlitic's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enlitic (ASX:ENL) has a EBITDA Margin % of -309.83% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Enlitic and its competitors. According to the industry distribution chart, Enlitic ranks #638 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 95.5%.
Is Enlitic's EBITDA Margin % too high?
Enlitic's current EBITDA Margin % is -309.83%. Based on the distribution chart, Enlitic ranks #638 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Enlitic's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Enlitic ranks #638 out of 668 companies for EBITDA Margin %. This places Enlitic in the lower half of its industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Enlitic and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enlitic's current EBITDA Margin % is -309.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enlitic stock overvalued right now?
Enlitic (ASX:ENL) has a current EBITDA Margin % of -309.83%. The current EBITDA Margin % is -309.83%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Enlitic (ASX:ENL), the current EBITDA Margin % is -309.83% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Enlitic Inc is the AI-enabled healthcare revolution. The company has developed an intelligent data framework that powers critical workflows, orchestrates data, and enables greater comprehension of what information resides in archives thereby unlocking new revenue opportunities, generating cost savings, and improving healthcare delivery. It provides solutions for Radiologists, IT Professionals, Executives, and Researchers. The Group has two operating segments: Software includes intelligently managing healthcare data using the power of artificial intelligence to expand capacity and improve clinical workflows, etc; and Migration services Transfer large volumes of imaging data to allow for the smooth transition of software solutions for healthcare vendors and providers and Migration services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ENL has been successfully added to your